What is the price target for SMG stock?
11 analysts have analysed SMG and the average price target is 74.66 USD. This implies a price increase of 15.81% is expected in the next year compared to the current price of 64.47.
NYSE:SMG • US8101861065
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SCOTTS MIRACLE-GRO CO (SMG).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-03 | Stifel | Maintains | Buy -> Buy |
| 2026-01-29 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-01-14 | UBS | Maintains | Neutral -> Neutral |
| 2025-11-06 | UBS | Maintains | Neutral -> Neutral |
| 2025-11-06 | Stifel | Upgrade | Hold -> Buy |
| 2025-11-05 | Jefferies | Maintains | Buy -> Buy |
| 2025-10-02 | UBS | Maintains | Neutral -> Neutral |
| 2025-09-25 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-08-04 | Stifel | Maintains | Hold -> Hold |
| 2025-07-31 | UBS | Maintains | Neutral -> Neutral |
| 2025-07-17 | UBS | Maintains | Neutral -> Neutral |
| 2025-07-14 | Truist Securities | Maintains | Buy -> Buy |
| 2025-07-09 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-06-09 | Stifel | Downgrade | Buy -> Hold |
| 2025-06-06 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-06-06 | Truist Securities | Maintains | Buy -> Buy |
| 2025-05-13 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-05-01 | UBS | Maintains | Neutral -> Neutral |
| 2025-05-01 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-04-17 | UBS | Maintains | Neutral -> Neutral |
| 2025-04-16 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-04-07 | Jefferies | Upgrade | Hold -> Buy |
| 2025-04-02 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-04-02 | Truist Securities | Upgrade | Hold -> Buy |
| 2025-03-04 | Stifel | Upgrade | Hold -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.551B -9.50% | 3.553B 0.04% | 3.413B -3.93% | 3.345B -2.00% | 3.43B 2.54% | 3.52B 2.62% | 3.728B 5.91% | 3.886B 4.24% | 3.903B 0.44% | 4.035B 3.38% | 4.17B 3.35% | |
| EBITDA YoY % growth | 384.3M -26.72% | 435.7M 13.37% | 517.3M 18.73% | 603.16M 16.60% | 645.63M 7.04% | 689.71M 6.83% | 743.76M 7.84% | 790.98M 6.35% | 792.55M 0.20% | 840.42M 6.04% | 890.42M 5.95% | |
| EBIT YoY % growth | 291.8M -30.39% | 355.1M 21.69% | 442.3M 24.56% | 484.37M 9.51% | 520.43M 7.44% | 544.61M 4.65% | 593.48M 8.97% | 635.69M 7.11% | 607.11M -4.50% | 648.72M 6.85% | 692.25M 6.71% | |
| Operating Margin | 8.22% | 10.00% | 12.96% | 14.48% | 15.17% | 15.47% | 15.92% | 16.36% | 15.55% | 16.08% | 16.60% | |
| EPS YoY % growth | 1.16 -71.64% | 2.24 93.10% | 3.72 66.07% | 4.34 16.57% | 4.93 13.73% | 5.52 12.01% | 6.48 17.28% | 7.26 12.00% | 7.42 2.30% | 8.35 12.52% | 9.35 11.97% |
All data in USD
| Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 4.02 1.01% | 2.88 11.02% | -1.75 10.64% | -0.85 -10.14% | 4.34 7.94% | 3.18 10.76% | -1.62 7.74% | -0.80 5.92% | 5.18 19.40% | 3.68 15.43% | -1.83 -13.12% |
| Revenue Q2Q % growth | 1.418B -0.21% | 1.225B 3.11% | 381.29M -1.58% | 367.19M 3.61% | 1.473B 3.88% | 1.299B 6.04% | 389.88M 2.25% | 355.24M -3.25% | 1.515B 2.85% | 1.321B 1.69% | 393.69M 0.98% |
| EBITDA Q2Q % growth | 399.67M -0.23% | 282.18M 1.65% | -80.186M -116.13% | -5.353M -1,684.33% | 427.17M 6.88% | 309.75M 9.77% | -73.003M 8.96% | 2.596M 148.50% | 461.33M 8.00% | 311.79M 0.66% | -79.265M -8.58% |
| EBIT Q2Q % growth | 368.89M 1.71% | 246.86M 11.65% | -108.372M 3.33% | -31.086M -66.23% | 400.08M 8.46% | 276.58M 12.04% | -97.744M 9.81% | -21.362M 31.28% | 437.57M 9.37% | 288.2M 4.20% | -102.626M -5.00% |
All data in USD
11 analysts have analysed SMG and the average price target is 74.66 USD. This implies a price increase of 15.81% is expected in the next year compared to the current price of 64.47.
SCOTTS MIRACLE-GRO CO (SMG) will report earnings on 2026-04-29, before the market open.
The consensus EPS estimate for the next earnings of SCOTTS MIRACLE-GRO CO (SMG) is 4.02 USD and the consensus revenue estimate is 1.42B USD.
The number of analysts covering SCOTTS MIRACLE-GRO CO (SMG) is 11.